Syngenta to Establish £100m Bioscience Research Centre in the UK
Syngenta, a major global agrichemical group owned by China National Chemical Corporation, has announced plans to construct a new £100 million bioscience hub in Berkshire. This significant investment is set to enhance the company's research capabilities in agricultural technologies, with a particular focus on biological pesticides and artificial intelligence tools.
Boost for UK Science and Relations with Industry
The decision to build the research centre at Syngenta's Jealott's Hill site comes as a positive development for the UK's science sector. It follows recent tensions between the government and the pharmaceutical industry, which led to the cancellation or pausing of nearly £2 billion in investments by major drugmakers last year. Notably, AstraZeneca's £200 million expansion in Cambridge remains on hold.
Angela Eagle, the UK farming minister, praised the move, describing it as "a clear vote of confidence in the UK and our world-leading agricultural science." She highlighted that the government is supporting sustainable farming through £345 million in grants for equipment and innovation.
Focus on Advanced Agricultural Technologies
The new hub, named BioSTaR (Biological Sciences Technology and Research), will consolidate Syngenta's bioscience operations, housing approximately 300 scientists. While no new jobs are planned initially, the centre will leverage AI to drive research into next-generation crop protection methods. These include developing sustainable solutions that respond to environmental factors like temperature and soil quality, and preempting resistance issues.
Camilla Corsi, Syngenta's global head of crop protection R&D, stated, "We are focused on creating a more productive and sustainable future for agriculture. With this investment, we are pushing the boundaries of science."
Background and Broader Context
Syngenta, founded in 2000 from the merger of Novartis and AstraZeneca's agrichemical divisions, employs over 2,000 people across six UK sites. The Jealott's Hill location is its largest R&D site worldwide, with 800 staff working in areas such as global product safety and digital imaging. The company reported sales of about £23 million in 2024 and is reportedly considering a stock market listing in Hong Kong to raise up to £7.5 million.
In a related development, Syngenta recently announced it will cease global production of the weed killer paraquat by the end of June, citing competition from generic producers. The company faces numerous lawsuits in the US over alleged links between paraquat exposure and Parkinson's disease.
The new bioscience hub is expected to be completed by 2028, marking a strategic step in advancing agricultural innovation and reinforcing the UK's position in global research.
